About Eicos Sciences
Eicos Sciences is a company based in San Mateo (United States) founded in 2016. It operates as a B2B. The company has 9 employees as of December 31, 2022. Eicos Sciences offers products and services including Prostacyclin Analogues. Eicos Sciences operates in a competitive market with competitors including Amryt Pharma, Castle Creek Biosciences, QID Pharma and LifeMax, among others.
- Headquarter San Mateo, United States
- Employees 9 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Civi Biopharma, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
9
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Eicos Sciences
Eicos Sciences offers a comprehensive portfolio of products and services, including Prostacyclin Analogues.
Develops drugs targeting vasodilation and inflammation for rare diseases.
Funding Insights of Eicos Sciences
Detailed funding history for Eicos Sciences
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Eicos Sciences
Investment portfolio details for Eicos Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Eicos Sciences
Detailed financials for Eicos Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Eicos Sciences Comparisons
Peer comparison for Eicos Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Eicos Sciences
Eicos Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amryt Pharma, Castle Creek Biosciences, QID Pharma and LifeMax, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for rare dermatological and orphan diseases are developed.
|
|
| Locked | Locked | Locked |
Gene therapy platform for rare disease treatments is developed.
|
|
| Locked | Locked | Locked |
Therapeutics for rare genetic dermatology disorders are developed.
|
|
| Locked | Locked | Locked |
Develops innovative therapeutic solutions for Netherton syndrome treatment.
|
Detailed competitors of Eicos Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Eicos Sciences
Complete news archive for Eicos Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eicos Sciences
Eicos Sciences was founded in 2016.
Eicos Sciences is headquartered in San Mateo, United States. It is registered at San Mateo, California, United States.
As of Dec 31, 2022, the latest employee count at Eicos Sciences is 9.
Eicos Sciences is a biotechnology company focused on researching and developing Prostacyclin analogues, which act as vasodilators with antiplatelet and anti-inflammatory properties. The company targets debilitating conditions like frostbite, systemic sclerosis, and ECMO, where treatment options are scarce. Based in San Mateo, California, it operates as a subsidiary of CiVi Biopharma Holding Corp., aiming to improve patient outcomes through innovative science and therapeutic pipelines.
Eicos Sciences's top competitors include Castle Creek Biosciences, Amryt Pharma and QID Pharma.
Eicos Sciences offers Prostacyclin Analogues.